# Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)

> **NCT07239791** · NA · RECRUITING · sponsor: **Centre Hospitalier St Anne** · enrollment: 160 (estimated)

## Conditions studied

- Role of the Noradrenergic System in the Regulation of Learning Dynamics
- No Disease or Condition is Being Studied

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07239791
- **Lead sponsor:** Centre Hospitalier St Anne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-18
- **Primary completion:** 2027-11
- **Final completion:** 2027-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239791, "Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07239791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*